- Home
- FI vs SYK Comparison
FI vs SYK Comparison
Compare FI & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FI
- SYK
- Stock Information
- Founded
- FI 1984
- SYK 1941
- Country
- FI United States
- SYK United States
- Employees
- FI N/A
- SYK N/A
- Industry
- FI Business Services
- SYK Medical/Dental Instruments
- Sector
- FI Consumer Discretionary
- SYK Health Care
- Exchange
- FI Nasdaq
- SYK Nasdaq
- Market Cap
- FI 124.0B
- SYK 139.4B
- IPO Year
- FI 1986
- SYK N/A
- Fundamental
- Price
- FI $208.63
- SYK $383.55
- Analyst Decision
- FI Buy
- SYK Buy
- Analyst Count
- FI 26
- SYK 20
- Target Price
- FI $222.84
- SYK $408.21
- AVG Volume (30 Days)
- FI 2.4M
- SYK 1.3M
- Earning Date
- FI 02-05-2025
- SYK 01-28-2025
- Dividend Yield
- FI N/A
- SYK 0.88%
- EPS Growth
- FI 8.67
- SYK 38.37
- EPS
- FI 5.19
- SYK 9.33
- Revenue
- FI $20,122,000,000.00
- SYK $21,974,000,000.00
- Revenue This Year
- FI $3.48
- SYK $11.30
- Revenue Next Year
- FI $8.44
- SYK $8.08
- P/E Ratio
- FI $40.19
- SYK $41.11
- Revenue Growth
- FI 6.99
- SYK 10.51
- 52 Week Low
- FI $137.13
- SYK $307.23
- 52 Week High
- FI $223.23
- SYK $398.20
- Technical
- Relative Strength Index (RSI)
- FI 55.04
- SYK 62.50
- Support Level
- FI $199.52
- SYK $359.32
- Resistance Level
- FI $208.99
- SYK $368.82
- Average True Range (ATR)
- FI 3.14
- SYK 6.66
- MACD
- FI 0.30
- SYK 2.65
- Stochastic Oscillator
- FI 92.58
- SYK 90.39
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.